Pulmatrix (NASDAQ: PULM) Investor Presentation 9/5/2018
Pulmatrix (NASDAQ: PULM) Investor Presentation
CEO Interview
Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.
Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox. […]
Healthcare
CytoDyn (OTC: CYDY) Files Pivotal Trial Protocol for HIV Monotherapy with FDA
VANCOUVER, Washington, May 15, 2019 — After four years of monotherapy trials, data is now available to submit the long-anticipated pivotal trial for monotherapy to the FDA Trial will include 10 weeks of induction therapy […]
Healthcare
CytoDyn (OTC: CYDY) and Samsung BioLogics Formalize Manufacturing Partnership
INCHEON, South Korea, May 30, 2019 – CytoDyn Inc., (OTC: CYDY) a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications and Samsung BioLogics met at […]